{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:43:12Z","timestamp":1790692992339,"version":"4.1.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T00:00:00Z","timestamp":1491523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0175054","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T18:05:59Z","timestamp":1491588359000},"page":"e0175054","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Statin adherence and the risk of Parkinson's disease: A population-based cohort study"],"prefix":"10.1371","volume":"12","author":[{"given":"Violetta","family":"Rozani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nir","family":"Giladi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baruch","family":"El-Ad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Gurevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Tsamir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Hemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chava","family":"Peretz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,4,7]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1111\/j.1471-4159.2008.05254.x","article-title":"Statins reduce neuronal alpha-synuclein aggregation in in vitro models of Parkinson&apos;s disease","volume":"105","author":"P Bar-On","year":"2008","journal-title":"J Neurochem"},{"issue":"43","key":"ref2","doi-asserted-by":"crossref","first-page":"13543","DOI":"10.1523\/JNEUROSCI.4144-09.2009","article-title":"Simvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson&apos;s disease","volume":"29","author":"A Ghosh","year":"2009","journal-title":"J Neurosci"},{"issue":"1-2","key":"ref3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2004.02.083","article-title":"Simvastatin prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced striatal dopamine depletion and protein tyrosine nitration in mice","volume":"1037","author":"M Selley","year":"2005","journal-title":"Brain Res"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2165\/00002018-200831050-00004","article-title":"Use of statins and the risk of Parkinson&apos;s disease: a retrospective case-control study in the UK","volume":"31","author":"C Becker","year":"2008","journal-title":"Drug Saf"},{"issue":"11","key":"ref5","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jocn.2008.01.016","article-title":"Statin use and the risk of Parkinson disease: a nested case control study","volume":"15","author":"A Samii","year":"2008","journal-title":"J Clin Neurosci"},{"issue":"13","key":"ref6","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1002\/mds.21582","article-title":"Serum cholesterol, use of lipid-lowering drugs, and risk of Parkinson disease","volume":"22","author":"LM de Lau","year":"2007","journal-title":"Mov Disord"},{"issue":"340","key":"ref7","doi-asserted-by":"crossref","first-page":"c2197","DOI":"10.1136\/bmj.c2197","article-title":"Unintended effects of statins in men and women in England and Wales: populationbased cohort study using the QResearch database","volume":"20","author":"J Hippisley-Cox","year":"2010","journal-title":"BMJ"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1212\/01.wnl.0000286942.14552.51","article-title":"Statin use and the risk of Parkinson disease","volume":"70","author":"AD Wahner","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archneurol.2011.1060","article-title":"A prospective study of statin use and risk of Parkinson disease","volume":"69","author":"X Gao","year":"2012","journal-title":"Arch Neurol"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1212\/WNL.0b013e31829d873c","article-title":"Discontinuation of statin therapy associates with Parkinson disease: a population-based study","volume":"81","author":"YC Lee","year":"2013","journal-title":"Neurology"},{"issue":"8","key":"ref11","first-page":"626","article-title":"Long term statin use and the risk of Parkonson&apos;s disease","volume":"19","author":"B Fridman","year":"2013","journal-title":"Am J Manag Care"},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/mds.23102","article-title":"Statin use and Parkinson&apos;s disease in Denmark","volume":"25","author":"B Ritz","year":"2010","journal-title":"Mov Disord"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1741-7015-5-20","article-title":"Simvastatin is assosiated with a redused incidence of dementia and Parkinson&apos;s disease","volume":"5","author":"B Wolozin","year":"2007","journal-title":"BMC Mwd"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/mds.26152","article-title":"Statins, plasma cholesterol and risk of Parkinsons&apos; disease: a prospective study","volume":"30","author":"X Huang","year":"2015","journal-title":"Mov Disord"},{"issue":"9","key":"ref15","first-page":"923","article-title":"Dynamics of long-term statin therapy","volume":"69","author":"MJ Korhonen","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"ref16","first-page":"4049","article-title":"Confounding of the association between statins and Parkinson disease: systematic review and meta-analysis","volume":"16","author":"K Bykov","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/aje\/kwm070","article-title":"Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect","volume":"166","author":"MA Brookhart","year":"2007","journal-title":"Am J Epidemiol"},{"key":"ref18","unstructured":"World Health Organization Collaborating Centre for Drug Statistics Methodology ATC\/DDD Index. Norwegian Institute of Public Health. [Online]. 2015. Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.whocc.no\/atc_ddd_index\" xlink:type=\"simple\">http:\/\/www.whocc.no\/atc_ddd_index<\/ext-link>."},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00228-009-0701-0","article-title":"Protopathic bias in observational studies on statin effectiveness","volume":"65","author":"MJ Korhonen","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"issue":"16","key":"ref20","first-page":"300","article-title":"The lag-time approach improved drug-outcome association estimates in presence of protopathic bias","volume":"4356","author":"A Arf\u00e8","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/pds.3935","article-title":"Estimating time-varying drug adherence using electronic records: extending the proportion of days covered (PDC) method","volume":"25","author":"MJ Bijlsma","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"11","key":"ref22","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.clinthera.2008.11.012","article-title":"Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel","volume":"30","author":"G Chodick","year":"2008","journal-title":"Clin Ther"},{"key":"ref23","unstructured":"Tabenkin H, Lahad A. Clinical guidelines: Israeli task-force recommendations for health promotion and preventive health services. [Online]. 2013. Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ima.org.il\/Ima\/FormStorage\/Type1\/clinical_09_preventive.pdf\" xlink:type=\"simple\">http:\/\/www.ima.org.il\/Ima\/FormStorage\/Type1\/clinical_09_preventive.pdf<\/ext-link>. Published 2013."},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/aje\/kwh175","article-title":"Imputations of missing values in practice: results from imputations of serum cholesterol in 28 cohort studies","volume":"160","author":"F Barzi","year":"2004","journal-title":"American Journal of Epidemiology"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s40471-015-0050-8","article-title":"Are al biases missing data problems?","volume":"2","author":"C Howe","year":"2015","journal-title":"Curr Epidemiol Rep"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/JPD-2011-11024","article-title":"Use of a refined drug tracer algorithm to estimate prevalence and incidence of Parkinson&apos;s disease in a large Israeli population","volume":"1","author":"O Chillag-Talmor","year":"2011","journal-title":"J Parkinsons Dis"},{"key":"ref27","unstructured":"U.S. Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood. Your guide to lowering your cholesterol with therapeutic lifestyle changes. [Online]. 2005. Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.nhlbi.nih.gov\/files\/docs\/public\/heart\/chol_tlc.pdf\" xlink:type=\"simple\">http:\/\/www.nhlbi.nih.gov\/files\/docs\/public\/heart\/chol_tlc.pdf<\/ext-link>."},{"issue":"7","key":"ref28","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1001\/archneurol.2010.135","article-title":"When does Parkinson disease start?","volume":"67","author":"R Savica","year":"2010","journal-title":"Arch Neurol"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/1381612822666151109111511","article-title":"All for statins and statins for all; An Update","volume":"22","author":"AP Agouridis","year":"2015","journal-title":"Curr Pharm Des"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1212\/WNL.0b013e31829d87bb","article-title":"Holding on to statins in Parkinson disease","volume":"81","author":"EK Tan","year":"2013","journal-title":"Neurology"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/aje\/kwm324","article-title":"Immortal time bias in pharmaco-epidemiology","volume":"164","author":"S Suissa","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"11","key":"ref32","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.jclinepi.2012.04.008","article-title":"Time-dependent study entries and exposures in cohort studies can easily be sources of different and avoidable types of bias","volume":"65","author":"M Wolkewitz","year":"2012","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jama.288.4.455","article-title":"Long-term persistence in use of statin therapy in elderly patients","volume":"288","author":"JS Benner","year":"2002","journal-title":"JAMA"},{"issue":"8","key":"ref34","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archinte.167.8.847","article-title":"Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use","volume":"167","author":"MA Brookhart","year":"2007","journal-title":"Arch Intern Med"},{"issue":"Suppl1","key":"ref35","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1007\/s10654-011-9581-6","article-title":"Epidemiology and etiology of Parkinson&apos;s disease: a review of the evidence","volume":"26","author":"K Wirdefeldt","year":"2011","journal-title":"Eur J Epidemiol 2011"},{"issue":"5","key":"ref36","first-page":"1513","article-title":"\u03b1-Synuclein in the olfactory system in Parkinson&apos;s disease: role of neural connections on spreading pathology","volume":"219","author":"I Ubeda-Ba\u00f1on","year":"2014","journal-title":"Brain Struct Funct"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1212\/WNL.0b013e3181ec7fac","article-title":"REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century","volume":"75","author":"DO Claassen","year":"2010","journal-title":"Neurology"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.expneurol.2010.04.006","article-title":"Statins: multiple neuroprotective mechanisms in neurodegenerative diseases","volume":"230","author":"Q Wang","year":"2011","journal-title":"Exp Neurol"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2174\/092986707779313462","article-title":"The therapeutic potential of statins in neurological disorders","volume":"14","author":"G Rajanikant","year":"2007","journal-title":"Curr Med Chem"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0175054","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T04:56:10Z","timestamp":1601873770000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0175054"}},"subtitle":[],"editor":[{"given":"Gianluigi","family":"Forloni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,4,7]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,4,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0175054","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,7]]}}}